Metraipolis › archive › dc_119ae23de92a
Advancements in the utilization of immune checkpoint inhibitors for the treatment of gynecological tumors — Europe PMC PMID:41983132
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41983132
- DOI
- 10.3389/fimmu.2026.1686568
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T16:21:44.831Z
- SHA-256 of the archived text
31d9a36b797a0e78121f6883cdb49db8c1f694dfeedb2a53115b97c9cf33d6c9- Stable URL of this page
https://metraipolis.com/documento/dc_119ae23de92a
How to cite
Advancements in the utilization of immune checkpoint inhibitors for the treatment of gynecological tumors — Europe PMC PMID:41983132 — Europe PMC (en), https://europepmc.org/article/MED/41983132 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_119ae23de92a (Metraipolis archive dc_119ae23de92a, sha256 31d9a36b797a0e78121f6883cdb49db8c1f694dfeedb2a53115b97c9cf33d6c9)
BibTeX
@misc{dc119ae23de92a,
title = {Advancements in the utilization of immune checkpoint inhibitors for the treatment of gynecological tumors — Europe PMC PMID:41983132},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41983132},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_119ae23de92a; sha256 31d9a36b797a0e78121f6883cdb49db8c1f694dfeedb2a53115b97c9cf33d6c9},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41983132. Agents can read the archived copy with the MCP tool read_document.